Earnings

Stock Earnings Report: Tenax Therapeutics Inc (NASDAQ:TENX)

Shares of Tenax Therapeutics Inc (NASDAQ:TENX) reached at $0.57 during previous trading session. The company has experienced volume of 1,679,739 shares.

Tenax Therapeutics Inc (NASDAQ:TENX) a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, on March 21, 2017 announced financial results for the full year ended December 31, 2016 and provided a corporate update.

Full Year 2016 Financial Results:

The Company reported a net loss of $44.0 million, or $(1.56) per share, for the year ended December 31, 2016, compared to a net loss of $15.9 million, or $(0.57) per share, for the prior year.

The Company reported general and administrative expenses of $6.2 million for the year ended December 31, 2016, compared to $6.7 million for the prior year.

The Company reported research and development expenses of $13.1 million for the year ended December 31, 2016, compared to $8.9 million for the prior year.

The Company reported a loss on impairment of assets of $33.3 million for the year ended December 31, 2016, compared to $1.0 million for the prior year.

As of December 31, 2016, the Company had $21.9 million in cash, including the fair value of its marketable securities, compared to $38.2 million at December 31, 2015.

Tenax Therapeutics Inc (NASDAQ:TENX) holds the market capitalization of $14.59M along with 28.12M outstanding shares. During the last trade, stock’s minimum price has been reached out at $0.54 while the maximum trading price moved at $0.65. Currently the stock price is moving -82.65% off from the highest level of twelve months and +22.89% above from twelve months low. Tenax Therapeutics Inc (NASDAQ:TENX) marked 52-week highest price level of $2.94 on 04/14/16 and 52-week lowest price level of $0.41 on 01/31/17. For the stock, price target value has been calculated at $9.25 based on calls of 2 experts. Stock’s minimum price target estimates has been figured out at $8.00 while the maximum price target forecast is established at $10.50.

As of current trade, Tenax Therapeutics Inc (NASDAQ:TENX) has shown weekly downbeat performance of -20.06%. Its six months performance indicated a bearish movement while its yearly performance reflected a negative trend of -71.91%. Year-to-date (YTD) performance of the stock illustrate downbeat trend of -70.90%. Shares of Tenax Therapeutics Inc (NASDAQ:TENX) currently have an ABR of 1.00, derived from a total of 1 opinions. The company’s price sits -55.35% below from its 50-day moving average of $0.69 and -73.78% below from the stock’s 200-day moving average of $1.66. The company has Relative Strength Index (RSI 14) of 23.62 along with Average True Range (ATR 14) of 0.06. Its weekly and monthly volatility is 11.96%, 8.38% respectively. The company’s beta value is at 0.80.

Tenax Therapeutics Inc (NASDAQ:TENX)’s price to book ratio for most recent quarter is 0.93, whereas price to cash per share for the most recent quarter is 1.20. Tenax Therapeutics Inc (NASDAQ:TENX)’s current ratio for most recent quarter of 2.20. Total debt to equity ratio of the company for most recent quarter is 0.00 whereas long term debt to equity ratio for most recent quarter is 0.00.

Previous ArticleNext Article